drugset

drugset / Trial / NCT00455208

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

NCT00455208 ↗

Phase 1/2 Unknown 20 enrolled Cura Biotech LLC

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the safety and efficacy of Cura-100 in treating rheumatoid arthritis and osteoarthritis.

Timeline

Start: 2007-05
Primary completion: —
Completion: 2008-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cura-100	Unknown	—	—

Indications